<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: drug enforcement</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'drug enforcement'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22drug+enforcement%22&t=%22drug+enforcement%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 03:01:11 +0100</lastBuildDate>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4600798&amp;cid=t_188041_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FNPe3p37WgVo%2F</link>
            <description>Hello, everyone, and nice to see you again. A spot of rain is falling on the Pharmalot corporate campus, but our spirits remain sunny. Of course, a cup or two of stimulation can help - our flavor this morning is Rain Forest Nut. Meanwhile, there are meetings and deadlines that await. So here are some interesting items to help you along. Have a great day and do stay in touch&amp;#8230;
Pfizer To Move Antibacterials Research To Shanghai (The Day)
Abbott CEO Compensation Fell 2.5 Percent Last Year (Dow Jones)
DEA Seizes Execution Drug In Georgia (Associated Press)
Japan Nuclear Catastrophe Spurs Debate Over Radiation Pills (Bloomberg News)
Those $4 Rx Programs Can Save US Billions (Reuters)
Cephalon Sues US Over Fentora Generic Approval (Bloomberg News)
Aegerion Receives Orphan Status For Lipid D...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4600798</comments>
            <pubDate>Wed, 16 Mar 2011 11:53:04 +0100</pubDate>
            <guid isPermaLink="false">4600798</guid>        </item>
        <item>
            <title>DEA Commish, A Delayed Nomination &amp; Pain Meds</title>
            <link>http://www.medworm.com/index.php?rid=4183535&amp;cid=t_188041_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FG_Zu5woRr-M%2F</link>
            <description>For several months, the Drug Enforcement Agency has been locked in a battle with a US Senator, who is incensed the DEA initiated an enforcement action that makes it virtually impossible for nurses who work in long-term care facilities to prescribe needed pain meds. The DEA says the issue is illicit drug diversion, but Herb Kohl, a Wisconsin Democrat who chairs the Senate Special Committee on Aging, argues the move is not only illegal, but robs elderly patients of necessary treatment.
Some background: for years, nurses placed orders for pain meds - such as morphine - under verbal instructions from docs, who often were not present at the time. Why? These drugs are often needed in the middle of the night or on weekends. So prescriptions were relayed to a pharmacy by phone or fax and then fill...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4183535</comments>
            <pubDate>Fri, 19 Nov 2010 19:58:58 +0100</pubDate>
            <guid isPermaLink="false">4183535</guid>        </item>
        <item>
            <title>J&amp;J Pays $511K Fine For Pfizer Blunder</title>
            <link>http://www.medworm.com/index.php?rid=1683438&amp;cid=t_188041_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F356749327%2F</link>
            <description>The healthcare giant coughed up the money in order to settle federal allegations that a plant in Lititz, Pennsvylvania, which it acquired in 2006 as part of its purchase of Pfizer&amp;#8217;s consumer health care business, violated paperwork regulations for controlled substances, according to the US Attorney in Philadelphia (read the statement). 
The manufacturing plant was accused of importing controlled substances - in this case, Benadryl-D - from Canada without filing a notification with the US Drug Enforcement Agency between 2001 and 2005. The med contains pseudophedrine, which is a controlled substance pseudophedrine.
The Controlled Substances Act requires anyone who imports, distributes and dispenses controlled substances to report to the DEA any importation. The reports allow the agency...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1683438</comments>
            <pubDate>Tue, 05 Aug 2008 21:26:07 +0100</pubDate>
            <guid isPermaLink="false">1683438</guid>        </item>
        <item>
            <title>Meth to the West, Cocaine to the East, Pot in the Middle</title>
            <link>http://www.medworm.com/index.php?rid=1526544&amp;cid=t_188041_151_f&amp;fid=35823&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FAddictionInbox%2F%7E3%2F313942615%2Fmeth-to-west-cocaine-to-east-pot-in.html</link>
            <description>The geography of drug use.To paraphrase an old tune by Gerry Rafferty, we got meth to the left of us, cocaine to the right, and here we are, stuck in the middle with pot.The National Drug Threat Survey of 2007, a product of the National Drug Intelligence Center (NDIC) at the Department of Justice, illustrates the stark nature of regional variation when it comes to illegal drugs of choice in the United States. The map at the right represents the responses of state and local law enforcement agencies to the question: &quot;What drug poses the greatest threat to your area?&quot; Blue indicates cocaine, red indicates methamphetamine, and green stands for marijuana.      (Click map for larger image.)According to the Oregonian in Portland, reporting on similar numbers from the U.S. Substance Abuse and Ment...</description>
            <author>Addiction Inbox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1526544</comments>
            <pubDate>Tue, 17 Jun 2008 17:04:00 +0100</pubDate>
            <guid isPermaLink="false">1526544</guid>        </item>
        <item>
            <title>Important information about nandrolone in the us</title>
            <link>http://www.medworm.com/index.php?rid=1309054&amp;cid=t_188041_135_f&amp;fid=35262&amp;url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2008%2F03%2Fimportant-information-about-nandrolone.html</link>
            <description>QUESTION FROM SOMEONE IN MY POZHEALTH AT YAHOOGROUPS.COM LIST:&quot;I interpret this that once the current supply of the components tomake nandrolone are depleted, there will be no more access tonandrolone here in the US. Am I right or just the number ofcompounding pharmacies may continue to dwindle due to DEA pressures?Thanks everyone,Tom A&quot;MY ANSWER:Dear TomThe ingredients to make nandrolone are not depleted. The decision from the manufacturer (Watson) to stop making nandrolone decanoate (an effective injectable medicine to treat unintentional weight loss and to increase muscle mass) was based on economics and political pressure.Watson stopped making it because:1- It is a generic CHEAP drug2- They can sell expensive Oxandrin instead. Oxandrin is approved for unintentional weight loss but cost...</description>
            <author>Nelson Vergel's HIV Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1309054</comments>
            <pubDate>Mon, 17 Mar 2008 21:52:00 +0100</pubDate>
            <guid isPermaLink="false">1309054</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Time For A Break</title>
            <link>http://www.medworm.com/index.php?rid=1106342&amp;cid=t_188041_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F202868283%2F</link>
            <description>Grey skies and chilly temperatures can mean only one thing - a cup of coffee. And so we shall venture out in search of something of hot and delicious. We hope you have a chance to do the same. And here are a few of the latest missives to help you digest&amp;#8230;.
Enzon Tries To Remake Itself (NJ.com)
Idera Licenses Drug Technology To Merck KGaA (Yahoo/AP)
DEA Eases Restrictions On Some Meds (Bloomberg News)
Genzyme Osteoarthritis Drug Gets EU OK (Yahoo/AP)
Glaxo Completes $1.65 Billion Acquisition Of Reliant (MarketWatch)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1106342</comments>
            <pubDate>Wed, 19 Dec 2007 18:11:18 +0100</pubDate>
            <guid isPermaLink="false">1106342</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Is Here</title>
            <link>http://www.medworm.com/index.php?rid=1063010&amp;cid=t_188041_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F193247012%2F</link>
            <description>And so we turn our attention to other matters, such as raking leaves and spending time with our short people. We may even read a book. And you? Whatever your passion, we hope you enjoy the time. Meanwhile, here are a few items to help you stay abreast, even as other activities beckon&amp;#8230;
Amgen&amp;#8217;s Aranesp Data Disappoints (TheStreet.com)
Fosamax Users Seek Class-Action Lawsuit Status (Yahoo/AP)
King Pharma Options Up On Takeover Speculation (Yahoo/Reuters)
DEA Move May Not Hurt Cardinal Health (Yahoo/AP)
UK&amp;#8217;s NHS Calls For Redirecting Cancer Med Expenditures (BBC)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1063010</comments>
            <pubDate>Sat, 01 Dec 2007 01:16:58 +0100</pubDate>
            <guid isPermaLink="false">1063010</guid>        </item>
    </channel>
</rss>

